Satoshi Yasuda

15PUBLICATIONS
38CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCell physiologyIntensive careHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 03, 2026
Survival Outcomes of Gemcitabine-Cisplatin-S-1 Versus Gemcitabine-Cisplatin in Unresectable Biliary Tract Cancer: A Multicenter Retrospective Study With a Focus on Conversion Surgery.

|Jan 21, 2026
Clinicopathological Factors on Survival after Conversion Surgery for Unresectable Locally Advanced Pancreatic Cancer: A Nationwide Study by the Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Satoshi Yasuda, Sohei Satoi, Hideki Takami

|Jan 05, 2026
Potential Survival Benefit of Adjuvant Chemotherapy in Stage IV Intrahepatic Cholangiocarcinoma: A Multicenter, Stage-Stratified Analysis.

Hisashi Kosaka, Masaki Ueno, Hiroji Shinkawa

|Dec 24, 2025
Clinical Significance of Intratumoral Contrast Pooling on Contrast-Enhanced CT After Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma.

Kiyoyuki Minamiguchi, Mariko Irizato, Ryota Nakano

|Oct 11, 2025
Individualized Prognostication Based on Deep-Learning Models Using Computed Tomography as an Imaging Biomarker After Hepatocellular Carcinoma Resection.

Hiroji Shinkawa, Daiju Ueda, Sota Kurimoto

|Jun 26, 2025
Risk for Recurrence After Liver Resection in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Detected After Sustained Virological Response by Direct-Acting Antivirals: A Retrospective Multicenter Study.

Shogo Tanaka, Takehiro Noda, Koji Komeda

Pageof 3

Frequent Collaborators

5 joint publications

Masayuki Sho

4 joint publications

Masahiko Kinoshita

4 joint publications

Masaki Ueno

3 joint publications

Minako Nagai